Autopsy report · NCT02091063

ACY-1215 for Relapsed/Refractory Lymphoid Malignancies

“Lack of funding”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 5 years 1 month before it stopped.
• 23 participants enrolled.
• Results were posted on the registry 5 years 3 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 1, Phase 2

Sponsor

Jennifer Amengual

Sponsor type

University, hospital or other

Conditions

Lymphoma; Lymphoid Malignancies

Interventions

ACY-1215

Participants

23

Sites

2

Countries

United States

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.